CB
Bandiera, Carole
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Using a Semiautomated Procedure (CleanADHdata.R Script) to Clean Electronic Adherence Monitoring Data: Tutorial | JMIR formative research |  | 2024 | 51 | 69 | ||
| The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study | Frontiers in pharmacology | | 2024 | 68 | 56 | ||
| Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study | Cancers | | 2024 | 60 | 83 | ||
| A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial | PloS one | | 2024 | 88 | 27 | ||
| Néphropathie diabétique : soutenir l’adhésion médicamenteuse de façon interprofessionnelle | Revue Médicale Suisse | | 2023 | 87 | 14 | ||
| An interprofessional intervention to support adherence to complex and polypharmacy treatments in patients with solid cancer and patients with diabetic kidney disease | | 2023 | 371 | 194 | |||
| Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study | Cancers | | 2023 | 169 | 78 | ||
| Swiss priority setting on implementing medication adherence interventions as part of the European ENABLE COST action | International journal of public health | | 2022 | 144 | 79 | ||
| Interventions to Support Adherence to Oral Anticancer Therapies: Research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland | Supportive care in cancer | | 2022 | 284 | 163 | ||
| Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study | Diabetology & metabolic syndrome | | 2022 | 117 | 88 | ||
| Medication adherence evaluated through electronic monitors during the 2020 COVID-19 pandemic lockdown in Switzerland: a longitudinal analysis | Patient preference and adherence | | 2022 | 150 | 76 | ||
| Population pharmacokinetics of palbociclib and its correlation with clinical efficacy and safety in patients with advanced breast cancer | Pharmaceutics | | 2022 | 127 | 117 | ||
| Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS) | JMIR Research Protocols | | 2021 | 451 | 232 | ||
| Optimizing oral targeted anticancer therapies study for patients with solid cancer: protocol for a randomized controlled medication adherence program along with systematic collection and modeling of pharmacokinetic and pharmacodynamic data | JMIR research protocols | | 2021 | 223 | 181 | ||
| Adhésion thérapeutique et collaboration médecin-pharmacien. L’exemple du patient avec néphropathie diabétique | Revue médicale suisse | | 2020 | 286 | 139 |
